Overall, these data advocate a more comprehensive and selective targeting of HPSE1 in tumors to avoid detrimental effects on effector T cell infiltration, while also supporting HPSE1 inhibitors as potential treatments in cardiovascular disease. Here, HPSE is linked to cardiovascular disorder.